Selected research
Market Analysis & Forecast
Global Oxiracetam API Market Analysis and Forecast 2026-2032
Market perspective
The global Oxiracetam API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oxiracetam API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Oxiracetam API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Oxiracetam API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Oxiracetam API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Oxiracetam API include Shaanxi Laon Biotech Co., Ltd., Shandong Green Chemical, Kono Chem Co.,Ltd., Chongqing Fuan Pharmaceutical, Union Pharma Co., Ltd., Shanghai CRM New Material Technology and Chemi SpA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oxiracetam API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Oxiracetam API, also provides the sales of main regions and countries. Of the upcoming market potential for Oxiracetam API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oxiracetam API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oxiracetam API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oxiracetam API sales, projected growth trends, production technology, application and end-user industry.
Oxiracetam API Segment by Company
Shaanxi Laon Biotech Co., Ltd.
Shandong Green Chemical
Kono Chem Co.,Ltd.
Chongqing Fuan Pharmaceutical
Union Pharma Co., Ltd.
Shanghai CRM New Material Technology
Chemi SpA
Oxiracetam API Segment by Type
Purity: 99%
Purity: >99%
Oxiracetam API Segment by Application
Oxiracetam Injection
Oxiracetam Tablets
Oxiracetam Capsules
Oxiracetam API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxiracetam API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxiracetam API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxiracetam API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Oxiracetam API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Oxiracetam API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oxiracetam API sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity: 99%
- Purity: >99%
Applications
- Oxiracetam Injection
- Oxiracetam Tablets
- Oxiracetam Capsules
Companies covered
- Shaanxi Laon Biotech Co., Ltd.
- Shandong Green Chemical
- Kono Chem Co.,Ltd.
- Chongqing Fuan Pharmaceutical
- Union Pharma Co., Ltd.
- Shanghai CRM New Material Technology
- Chemi SpA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Oxiracetam API Market by Type
- 1.2.1 Global Oxiracetam API Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Purity: 99%
- 1.2.3 Purity: >99%
- 1.3 Oxiracetam API Market by Application
- 1.3.1 Global Oxiracetam API Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Oxiracetam Injection
- 1.3.3 Oxiracetam Tablets
- 1.3.4 Oxiracetam Capsules
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Oxiracetam API Market Dynamics
- 2.1 Oxiracetam API Industry Trends
- 2.2 Oxiracetam API Industry Drivers
- 2.3 Oxiracetam API Industry Opportunities and Challenges
- 2.4 Oxiracetam API Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Oxiracetam API Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Oxiracetam API Revenue by Region
- 3.2.1 Global Oxiracetam API Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Oxiracetam API Revenue by Region (2021-2026)
- 3.2.3 Global Oxiracetam API Revenue by Region (2027-2032)
- 3.2.4 Global Oxiracetam API Revenue Market Share by Region (2021-2032)
- 3.3 Global Oxiracetam API Sales Estimates and Forecasts 2021-2032
- 3.4 Global Oxiracetam API Sales by Region
- 3.4.1 Global Oxiracetam API Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Oxiracetam API Sales by Region (2021-2026)
- 3.4.3 Global Oxiracetam API Sales by Region (2027-2032)
- 3.4.4 Global Oxiracetam API Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Oxiracetam API Revenue by Manufacturers
- 4.1.1 Global Oxiracetam API Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Oxiracetam API Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Oxiracetam API Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Oxiracetam API Sales by Manufacturers
- 4.2.1 Global Oxiracetam API Sales by Manufacturers (2021-2026)
- 4.2.2 Global Oxiracetam API Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Oxiracetam API Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Oxiracetam API Sales Price by Manufacturers (2021-2026)
- 4.4 Global Oxiracetam API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Oxiracetam API Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Oxiracetam API Manufacturers, Product Type & Application
- 4.7 Global Oxiracetam API Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Oxiracetam API Market CR5 and HHI
- 4.8.2 2025 Oxiracetam API Tier 1, Tier 2, and Tier 3
5 Oxiracetam API Market by Type
- 5.1 Global Oxiracetam API Revenue by Type
- 5.1.1 Global Oxiracetam API Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Oxiracetam API Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Oxiracetam API Revenue Market Share by Type (2021-2032)
- 5.2 Global Oxiracetam API Sales by Type
- 5.2.1 Global Oxiracetam API Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Oxiracetam API Sales by Type (2021-2032) & (tons)
- 5.2.3 Global Oxiracetam API Sales Market Share by Type (2021-2032)
- 5.3 Global Oxiracetam API Price by Type
6 Oxiracetam API Market by Application
- 6.1 Global Oxiracetam API Revenue by Application
- 6.1.1 Global Oxiracetam API Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Oxiracetam API Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Oxiracetam API Revenue Market Share by Application (2021-2032)
- 6.2 Global Oxiracetam API Sales by Application
- 6.2.1 Global Oxiracetam API Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Oxiracetam API Sales by Application (2021-2032) & (tons)
- 6.2.3 Global Oxiracetam API Sales Market Share by Application (2021-2032)
- 6.3 Global Oxiracetam API Price by Application
7 Company Profiles
- 7.1 Shaanxi Laon Biotech Co., Ltd.
- 7.1.1 Shaanxi Laon Biotech Co., Ltd. Company Information
- 7.1.2 Shaanxi Laon Biotech Co., Ltd. Business Overview
- 7.1.3 Shaanxi Laon Biotech Co., Ltd. Oxiracetam API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Shaanxi Laon Biotech Co., Ltd. Oxiracetam API Product Portfolio
- 7.1.5 Shaanxi Laon Biotech Co., Ltd. Recent Developments
- 7.2 Shandong Green Chemical
- 7.2.1 Shandong Green Chemical Company Information
- 7.2.2 Shandong Green Chemical Business Overview
- 7.2.3 Shandong Green Chemical Oxiracetam API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Shandong Green Chemical Oxiracetam API Product Portfolio
- 7.2.5 Shandong Green Chemical Recent Developments
- 7.3 Kono Chem Co.,Ltd.
- 7.3.1 Kono Chem Co.,Ltd. Company Information
- 7.3.2 Kono Chem Co.,Ltd. Business Overview
- 7.3.3 Kono Chem Co.,Ltd. Oxiracetam API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Kono Chem Co.,Ltd. Oxiracetam API Product Portfolio
- 7.3.5 Kono Chem Co.,Ltd. Recent Developments
- 7.4 Chongqing Fuan Pharmaceutical
- 7.4.1 Chongqing Fuan Pharmaceutical Company Information
- 7.4.2 Chongqing Fuan Pharmaceutical Business Overview
- 7.4.3 Chongqing Fuan Pharmaceutical Oxiracetam API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Chongqing Fuan Pharmaceutical Oxiracetam API Product Portfolio
- 7.4.5 Chongqing Fuan Pharmaceutical Recent Developments
- 7.5 Union Pharma Co., Ltd.
- 7.5.1 Union Pharma Co., Ltd. Company Information
- 7.5.2 Union Pharma Co., Ltd. Business Overview
- 7.5.3 Union Pharma Co., Ltd. Oxiracetam API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Union Pharma Co., Ltd. Oxiracetam API Product Portfolio
- 7.5.5 Union Pharma Co., Ltd. Recent Developments
- 7.6 Shanghai CRM New Material Technology
- 7.6.1 Shanghai CRM New Material Technology Company Information
- 7.6.2 Shanghai CRM New Material Technology Business Overview
- 7.6.3 Shanghai CRM New Material Technology Oxiracetam API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Shanghai CRM New Material Technology Oxiracetam API Product Portfolio
- 7.6.5 Shanghai CRM New Material Technology Recent Developments
- 7.7 Chemi SpA
- 7.7.1 Chemi SpA Company Information
- 7.7.2 Chemi SpA Business Overview
- 7.7.3 Chemi SpA Oxiracetam API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Chemi SpA Oxiracetam API Product Portfolio
- 7.7.5 Chemi SpA Recent Developments
8 North America
- 8.1 North America Oxiracetam API Market Size by Type
- 8.1.1 North America Oxiracetam API Revenue by Type (2021-2032)
- 8.1.2 North America Oxiracetam API Sales by Type (2021-2032)
- 8.1.3 North America Oxiracetam API Price by Type (2021-2032)
- 8.2 North America Oxiracetam API Market Size by Application
- 8.2.1 North America Oxiracetam API Revenue by Application (2021-2032)
- 8.2.2 North America Oxiracetam API Sales by Application (2021-2032)
- 8.2.3 North America Oxiracetam API Price by Application (2021-2032)
- 8.3 North America Oxiracetam API Market Size by Country
- 8.3.1 North America Oxiracetam API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Oxiracetam API Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Oxiracetam API Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Oxiracetam API Market Size by Type
- 9.1.1 Europe Oxiracetam API Revenue by Type (2021-2032)
- 9.1.2 Europe Oxiracetam API Sales by Type (2021-2032)
- 9.1.3 Europe Oxiracetam API Price by Type (2021-2032)
- 9.2 Europe Oxiracetam API Market Size by Application
- 9.2.1 Europe Oxiracetam API Revenue by Application (2021-2032)
- 9.2.2 Europe Oxiracetam API Sales by Application (2021-2032)
- 9.2.3 Europe Oxiracetam API Price by Application (2021-2032)
- 9.3 Europe Oxiracetam API Market Size by Country
- 9.3.1 Europe Oxiracetam API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Oxiracetam API Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Oxiracetam API Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Oxiracetam API Market Size by Type
- 10.1.1 China Oxiracetam API Revenue by Type (2021-2032)
- 10.1.2 China Oxiracetam API Sales by Type (2021-2032)
- 10.1.3 China Oxiracetam API Price by Type (2021-2032)
- 10.2 China Oxiracetam API Market Size by Application
- 10.2.1 China Oxiracetam API Revenue by Application (2021-2032)
- 10.2.2 China Oxiracetam API Sales by Application (2021-2032)
- 10.2.3 China Oxiracetam API Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Oxiracetam API Market Size by Type
- 11.1.1 Asia Oxiracetam API Revenue by Type (2021-2032)
- 11.1.2 Asia Oxiracetam API Sales by Type (2021-2032)
- 11.1.3 Asia Oxiracetam API Price by Type (2021-2032)
- 11.2 Asia Oxiracetam API Market Size by Application
- 11.2.1 Asia Oxiracetam API Revenue by Application (2021-2032)
- 11.2.2 Asia Oxiracetam API Sales by Application (2021-2032)
- 11.2.3 Asia Oxiracetam API Price by Application (2021-2032)
- 11.3 Asia Oxiracetam API Market Size by Country
- 11.3.1 Asia Oxiracetam API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Oxiracetam API Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Oxiracetam API Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Oxiracetam API Market Size by Type
- 12.1.1 SAMEA Oxiracetam API Revenue by Type (2021-2032)
- 12.1.2 SAMEA Oxiracetam API Sales by Type (2021-2032)
- 12.1.3 SAMEA Oxiracetam API Price by Type (2021-2032)
- 12.2 SAMEA Oxiracetam API Market Size by Application
- 12.2.1 SAMEA Oxiracetam API Revenue by Application (2021-2032)
- 12.2.2 SAMEA Oxiracetam API Sales by Application (2021-2032)
- 12.2.3 SAMEA Oxiracetam API Price by Application (2021-2032)
- 12.3 SAMEA Oxiracetam API Market Size by Country
- 12.3.1 SAMEA Oxiracetam API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Oxiracetam API Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Oxiracetam API Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Oxiracetam API Value Chain Analysis
- 13.1.1 Oxiracetam API Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Oxiracetam API Production Mode & Process
- 13.2 Oxiracetam API Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Oxiracetam API Distributors
- 13.2.3 Oxiracetam API Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst